Mitochondrial regulation of cancer associated nuclear DNA methylation

Biochemical and Biophysical Research Communications

Volumn 364, Issue 3, 2007, Pages 656-661

  Xie, Cheng hui ^a   Naito, Akihiro ^a   Mizumachi, Takatsugu ^a   Evans, Teresa T ^a   Douglas, Michael G ^a   Cooney, Craig A ^a   Fan, Chun Yang ^b   Higuchi, Masahiro ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cancer progression; CpG island hypermethylation; Mitochondrial DNA; Prostate cancer

Indexed keywords

CELL NUCLEUS DNA; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; ENDOTHELIN B RECEPTOR; GENE PRODUCT; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MITOCHONDRIAL DNA; UVOMORULIN;

ARTICLE; CANCER GROWTH; CELL LINE; CELL STRAIN LNCAP; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DISEASE COURSE; DNA CONTENT; DNA METHYLATION; ENZYME INHIBITION; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; MALE; METHYLATION; MITOCHONDRION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION;

CELL LINE, TUMOR; CELL NUCLEUS; CPG ISLANDS; DNA METHYLATION; DNA, MITOCHONDRIAL; DNA, NEOPLASM; HUMANS; MALE; MITOCHONDRIA; PROSTATIC NEOPLASMS;

EID: 35648947817     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.047     Document Type: Article

References (29)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer statistics. CA Cancer Journal for Clinicians 56 (2006) 106-130
2. Li L.C., Carroll P.R., and Dahiya R. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. Journal of the National Cancer Institute 97 (2005) 103-115
3. Baylin S.B., Makos M., Wu J.J., Yen R.W., de Bustros A., Vertino P., and Nelkin B.D. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells 3 (1991) 383-390
4. Chandel N.S., and Schumacker P.T. Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms. FEBS Letters 454 (1999) 173-176
5. King M.P., and Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246 (1989) 500-503
6. Higuchi M., Kudo T., Suzuki S., Evans T.T., Sasaki R., Wada Y., Shirakawa T., Sawyer J.R., and Gotoh A. Mitochondrial DNA determines androgen dependence in prostate cancer cell lines. Oncogene 25 (2006) 1437-1445
7. Munot K., Bell S.M., Lane S., Horgan K., Hanby A.M., and Speirs V. Pattern of expression of genes linked to epigenetic silencing in human breast cancer. Human Pathology 37 (2006) 989-999
8. Paul R., Ewing C.M., Jarrard D.F., and Isaacs W.B. The cadherin cell-cell adhesion pathway in prostate cancer progression. British Journal of Urology 1 (1997) 37-43
9. Yegnasubramanian S., Kowalski J., Gonzalgo M.L., Zahurak M., Piantadosi S., Walsh P.C., Bova G.S., De Marzo A.M., Isaacs W.B., and Nelson W.G. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Research 64 (2004) 1975-1986
10. King M.P., and Attardi G. Injection of mitochondria into human cells leads to a rapid replacement of the endogenous mitochondrial DNA. Cell 52 (1988) 811-819
11. Tanaka M., Hibasami H., Nagai J., and Ikeda T. Effect of 5-azacytidine on DNA methylation in Ehrlich's ascites tumor cells. Australian Journal of Experimental Biology & Medical Science 58 (1980) 391-396
12. Patra S.K., Patra A., Zhao H., and Dahiya R. DNA methyltransferase and demethylase in human prostate cancer. Molecular Carcinogenesis 33 (2002) 163-171
13. Wu J., Issa J.P., Herman J., Bassett Jr. D.E., Nelkin B.D., and Baylin S.B. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 8891-8895
14. Pirtskhalaishvili G., and Nelson J.B. Endothelium-derived factors as paracrine mediators of prostate cancer progression. Prostate 44 (2000) 77-87
15. Nelson J.B., Lee W.H., Nguyen S.H., Jarrard D.F., Brooks J.D., Magnuson S.R., Opgenorth T.J., Nelson W.G., and Bova G.S. Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Research 57 (1997) 35-37
16. Graff J.R., Herman J.G., Lapidus R.G., Chopra H., Xu R., Jarrard D.F., Isaacs W.B., Pitha P.M., Davidson N.E., and Baylin S.B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Research 55 (1995) 5195-5199
17. Amuthan G., Biswas G., Zhang S.Y., Klein-Szanto A., Vijayasarathy C., and Avadhani N.G. Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO Journal 20 (2001) 1910-1920
18. Wu H.C., Hsieh J.T., Gleave M.E., Brown N.M., Pathak S., and Chung L.W. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. International Journal of Cancer 57 (1994) 406-412
19. Culig Z., Klocker H., Eberle J., Kaspar F., Hobisch A., Cronauer M.V., and Bartsch G. DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 22 (1993) 11-22
20. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nature Reviews Genetics 3 (2002) 662-673
21. McCabe M.T., Davis J.N., and Day M.L. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Research 65 (2005) 3624-3632
22. Zhang Q., Wang H.Y., Woetmann A., Raghunath P.N., Odum N., and Wasik M.A. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood 108 (2006) 1058-1064
23. Biswas G., Anandatheerthavarada H.K., Zaidi M., and Avadhani N.G. Mitochondria to nucleus stress signaling: a distinctive mechanism of NFkappaB/Rel activation through calcineurin-mediated inactivation of IkappaBbeta. Journal of Cell Biology 161 (2003) 507-519
24. Higuchi M., Manna S.K., Sasaki R., and Aggarwal B.B. Regulation of the activation of nuclear factor kappaB by mitochondrial respiratory function: evidence for the reactive oxygen species-dependent and -independent pathways. Antioxidants & Redox Signaling 4 (2002) 945-955
25. Amuthan G., Biswas G., Ananadatheerthavarada H.K., Vijayasarathy C., Shephard H.M., and Avadhani N.G. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene 21 (2002) 7839-7849
26. Pelicano H., Xu R.H., Du M., Feng L., Sasaki R., Carew J.S., Hu Y., Ramdas L., Hu L., Keating M.J., Zhang W., Plunkett W., and Huang P. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. [see comment]. Journal of Cell Biology 175 (2006) 913-923
27. Carew J.S., and Huang P. Mitochondrial defects in cancer. Molecular Cancer 1 (2002) 1-12
28. Turner C.J., Granycome C., Hurst R., Pohler E., Juhola M.K., Juhola M.I., Jacobs H.T., Sutherland L., and Holt I.J. Systematic segregation to mutant mitochondrial DNA and accompanying loss of mitochondrial DNA in human NT2 teratocarcinoma Cybrids. Genetics 170 4 (2005) 1879-1885
29. Achanta G., Sasaki R., Feng L., Carew J.S., Lu W., Pelicano H., Keating M.J., and Huang P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO Journal 24 (2005) 3482-3492